FDA’s Top Vaccine Official Forced Out
In his resignation letter, Dr. Peter Marks cited “misinformation and lies” from Health and Human Services Secretary RFK Jr.
Top vaccine official Peter Marks forced out at FDA, WSJ reports
The U.S. Food and Drug Administration's top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal ...
Top vaccine official forced out of FDA
The head of the US Food and Drug Administration department responsible for assuring the safety and effectiveness of vaccines ...
New Scientist1d
GLP-1 drugs are only the start – the powerful drugs to expect next
The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...
Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
US FDA Approves Sanofi's Bleeding Disorder Therapy
Sanofi's subcutaneous, or under-the-skin, therapy helps prevent bleeding and lowers antithrombin, a protein that delays blood ...
Medetomidine is replacing xylazine in Philly street fentanyl − creating new hurdles for health care providers and drug users
Medetomidine is used in veterinary medicine, often during surgery. It's becoming common in the city's drug supplies, and it ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Gastroenterology Advisor2d
FDA Approves Gvoke VialDx to Inhibit GI Motility During Diagnostic Procedures
The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.
Endovascular Today2d
Vasorum’s Celt ACD Plus Vascular Closure Device Approved by FDA
Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...
Merck Buys Rights to Heart Disease Drug in Latest China Deal
Merck last year signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to ...
Agilent xCELLigence RTCA instrumentation applied in recent FDA approval
Technologies announces its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL, a recently approved CAR T therapy.